Effect of selenium supplementation on activity and mRNA expression of type 1 deiodinase in mice with excessive iodine intake

Biomedical and Environmental Sciences

Volumn 19, Issue 4, 2006, Pages 302-308

  Yang, Xue Feng ^a   Hou, Xiao Hui ^a   Xu, Jian ^a   Guo, Huai Lan ^a   Ying, Chen Jiang ^a   Chen, Xiao Yi ^a   Sun, Xiu Fa ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Excessive iodine; Glutathione peroxidase; Selenium; Type 1 deiodinase

Indexed keywords

ANTIOXIDANT; CREATININE; IODIDE PEROXIDASE; IODINE; IODOTHYRONINE DEIODINASE TYPE I; LIOTHYRONINE; MESSENGER RNA; SELENIUM; THYROXINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DIET SUPPLEMENTATION; FEMALE; GENETICS; KIDNEY; LIVER; METABOLISM; MOUSE; URINE;

ANIMALS; ANTIOXIDANTS; CREATININE; DIETARY SUPPLEMENTS; FEMALE; IODIDE PEROXIDASE; IODINE; KIDNEY; LIVER; MICE; MICE, INBRED BALB C; RNA, MESSENGER; SELENIUM; THYROXINE; TRIIODOTHYRONINE;

EID: 33749404286     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Laurberg P, Bulow P I, Knudsen N, et al. (2001). Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid 11, 457-469.
2. Markou K, Georgopoulos N, Kyriazopoulou V, et al. (2001). Iodine-induced hypothyroidism. Thyroid 11, 501-510.
3. Roti E, Uberti E D (2001). Iodine excessive and hyperthyroidism. Thyroid 11, 493-500.
4. Zhao J, Wang P, Shang L, et al. (2000). Endemic goiter associated with high iodine intake. Am J Public Health 90, 1633-1635.
5. Norimichi K, Horini M, Kenji Y, et al. (1994). Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 78, 393-397.
6. Pearce E N, Gerber A R, Gootnick D B, et al. (2002). Effects of chronic iodine excessive in a cohort of long-term American workers in west Africa. J Clin Endocrinol Metab 87, 5499-5502.
7. Zhao J, Chen Z, Maberly G F (1998). Iodine-rich drinking water of natural origin in China. Lancet 352, 2024.
8. Martino E, Bartalena L, Bogazzi F, et al. (2001). The effects of amiodarone on the thyroid. Endocr Rev 22, 240-254.
9. Delange F, de Benoist B, Alnwick D (1999). Risks of iodine-induced hyperthyroidism after correction of iodine deficiency by iodized salt. Thyroid 9, 545-556.
10. Chen Z, Liu D, Yang Y (1998). High iodine region and endemic iodine-induced goiter. Chin J Endemiol 17, 385-386.
11. Vitale M, Matola T D, d'Ascoli F (2000). Iodide excessive induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141, 598-605.
12. Danef J F, Many M C, van de Hove M F (1996). Iodine-induced thyroid inhibition and cell necrosis: two consequences of the same free-radical mediated mechanism. Mol Cell Endocrinol 121, 101-103.
13. Wolff J, Chaikoff I L (1948). Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174, 555-564.
14. Wu T, Wang J, Liu G (2000). A new hypothesis about iodine-induced goiter and hyperthyroidism: deiodinase activity decrease theory. West China Med J 115, 405-408.
15. Vesna B V, Franjo S, Ivana C (2004). Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta 341, 55-63.
16. Corvilain B, Contempre B, Longombe A O (1993). Selenium and the thyroid: how the relationship was established. Am J Clin Nutr 57, 244S-248S.
17. Berry M J, Banu L, Larsen P R (1991). Type I iodothyronine deiodinase is a selenocysteine- containing enzyme. Nature 349, 438-440.
18. Kohrle J (1999). Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol 151, 103-119.
19. Bednarczuk T, Pietrzykowski A, Slon M, et al (1993). Pharmacologic effect of excessive iodine on type I thyroxine 5′-deiodinase activity in rat thyroid. Endokrynol Pol 44, 405-412.
20. Merrill J C, Paul M C, Christian D W (1995). Tissue specificity of selenoprotein gene expression in rats. J Nutr Biochem 6, 367-372.
21. Hotz C S, Fitzpatrick D W, Trick K D, et al (1997). Dietary iodine and selenium interact to affect thyroid hormone metabolism of rats. J Nutr 127, 1214-1218.
22. 4+. Anal Chem 69, 687-689.
23. L'Abbe M R, Trick K D, Beare-Rogers J L (1991). Dietary (n-3) fatty acids deficiency may affect rat heart, liver, and aorta protective enzyme activities and lipid peroxidation. J Nutr 121, 1331-1340.
24. Hotz C S, Belonje B, Fitzpatrick D W, et al. (1996). A method for the determination of type I iodothyronine deiodinase activity in liver and kidney using 125I labelled reverse triiodothyronine as a substrate. Clin Biochem 29, 451-456.
25. Song S, Sorimachi K, Adachi K, et al. (2000). Biochemical and molecular biological evidence for the presence of type II iodothyronine deiodinase in mouse mammary gland. Mol Cell Endocrinol 160, 173-181.
26. -/-). Diabetes 49, 1116-1123.
27. Arthur J R (1999). Functional indicators of iodine and selenium status. Proc Nutr Soc 58, 507-512.
28. Kohrle J (1999). The trace element selenium and the thyroid gland. Biochimie 81, 527-533.
29. Xiang J M, Chen Z P, and Di H J (1999). Effects of iodine excessive on antioxidizing ability of mice. Chin J Endemiol 18, 245-249.
30. DePalo D, Kinlaw W B, Zhao C, et al (1994). Effect of selenium deficiency on type I 5′-deiodinase. J Biol Chem 269, 16223-16228.